Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid
about
Retinoids induce cellular senescence in breast cancer cells by RAR-β dependent and independent pathways: Potential clinical implications (Review)Bexarotene: a promising anticancer agentEpigallocatechin 3-gallate and green tea catechins: United they work, divided they failCDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism.Metabolism and regulation of gene expression by 4-oxoretinol versus all-trans retinoic acid in normal human mammary epithelial cells.Targeting HER2 Positive Breast Cancer with Chemopreventive Agents.Retinoids and rexinoids in cancer prevention: from laboratory to clinic.Association between dietary inflammatory potential and breast cancer incidence and death: results from the Women's Health Initiative.5-Lipoxygenase metabolic contributions to NSAID-induced organ toxicity.Antitumor effect of retinoic acid receptor-beta2 associated with suppression of cyclooxygenase-2.Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer.Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.Cyclooxygenase-2 expression in retinoblastoma: an immunohistochemical analysis.Retinoid X receptor agonists inhibit hypertension-induced myocardial hypertrophy by modulating LKB1/AMPK/p70S6K signaling pathway.
P2860
Q28081010-6F95F373-6554-4BC3-8C20-CFF6017A4E4DQ28259488-67B4F381-36E0-4D39-9ACD-DA645D97FECFQ33655389-EA60ECBF-123C-4B0A-828B-C6910F8C169EQ35656210-C5181E4A-0076-4D4E-A47D-F55B98FCC9CDQ35688497-54A3E6BE-2DDF-4350-BD4A-F0458D4991D1Q35860799-6182E716-55FF-4528-B68C-3376CC538FC0Q36114852-6CEFACB7-D2EF-4294-BEC5-1C4D49E28032Q36680198-52866055-B7EE-4466-BE1F-B7307E61B7B1Q36964372-7B615763-0348-4772-AC1E-9AE08263ED02Q37986694-E3478597-F2E1-4408-B3F6-15B22ABBCDCBQ42269301-FF7ABAD9-E7EE-4F23-8FEB-2C44457DECE6Q42561379-520B2988-33D9-45DB-AB26-B097BAC98002Q43061636-B453B320-A77F-46F0-84E6-E761C9E349D1Q43107306-4A84F05B-F0B3-467C-A3EF-C73E9985F5B5Q54372533-B0B2F9E4-7CBD-4409-8E28-9EA4E92BBB12
P2860
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combination chemoprevention of ...... X receptor-selective retinoid
@en
Combination chemoprevention of ...... X receptor-selective retinoid.
@nl
type
label
Combination chemoprevention of ...... X receptor-selective retinoid
@en
Combination chemoprevention of ...... X receptor-selective retinoid.
@nl
prefLabel
Combination chemoprevention of ...... X receptor-selective retinoid
@en
Combination chemoprevention of ...... X receptor-selective retinoid.
@nl
P2093
P2860
P1476
Combination chemoprevention of ...... X receptor-selective retinoid
@en
P2093
Amoi P Salmon
Andrew J Dannenberg
Kotha Subbaramaiah
Louise R Howe
Peiying Yang
Powel H Brown
Rebecca Baker
Reid P Bissonnette
Robert A Newman
Xi Kathy Zhou
P2860
P304
P356
10.1158/1940-6207.CAPR-08-0021
P577
2008-08-01T00:00:00Z